{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:22:15Z","timestamp":1791469335408,"version":"4.3.4"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejim.2021.06.023","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:25:42Z","timestamp":1625271942000},"page":"121-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Hyperhomocysteinemia in patients with acute porphyrias: a possible effect of ALAS1 modulation by siRNAm therapy and its control by vitamin supplementation"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-3750","authenticated-orcid":false,"given":"Andrea","family":"Ricci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Marcacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cuoghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Pietrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1893-1914","authenticated-orcid":false,"given":"Paolo","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2021.06.023_bib0001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ejim.2014.03.011","article-title":"A challenging diagnosis for potential fatal diseases: recommendations for diagnosing acute porphyrias","volume":"25","author":"Ventura","year":"2014","journal-title":"Eur J Int Med"},{"issue":"24","key":"10.1016\/j.ejim.2021.06.023_bib0002","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa1913147","article-title":"Phase 3 trial of rnai therapeutic givosiran for acute intermittent porphyria","volume":"382","author":"Balwani","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejim.2021.06.023_bib0003","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.nutr.19.1.217","article-title":"Homocysteine metabolism","volume":"19","author":"Selhub","year":"1999","journal-title":"Ann Rev Nutr"},{"key":"10.1016\/j.ejim.2021.06.023_bib0004","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.metabol.2010.05.016","article-title":"Preliminary report: hyperhomocysteinemia in patients with acute intermittent porphyria","volume":"59","author":"To-Figueras","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.ejim.2021.06.023_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejim.2020.04.002","article-title":"Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad?","volume":"79","author":"Ventura","year":"2020","journal-title":"Eur J Int Med"},{"key":"10.1016\/j.ejim.2021.06.023_bib0006","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00277-021-04547-3","article-title":"Severe homocysteinemia in two givosiran\u2011treated porphyria patients:is free heme deficiency the culprit?","volume":"100","author":"Petrides","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ejim.2021.06.023_bib0007","first-page":"1","article-title":"Dysregulation of homocysteine homeostasis in acute intermittent porphyria patients receiving heme arginate or Givosiran","author":"To-Figueras","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2021.06.023_bib0008","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.freeradbiomed.2017.10.389","article-title":"Nitration-mediated deficiency of cystathionine \u03b2-synthase activity accelerates the progression of hyperhomocysteinemia","volume":"113","author":"Wang","year":"2017","journal-title":"Free Rad Biol Med"},{"issue":"2","key":"10.1016\/j.ejim.2021.06.023_bib0009","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1074\/jbc.C115.680488","article-title":"Tetrahydrobiopterin biosynthesis as a potential target of the kynurenine pathway metabolite xanthurenic acid","volume":"291","author":"Haruki","year":"2016","journal-title":"J of Biol Chem"},{"key":"10.1016\/j.ejim.2021.06.023_bib0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jchromb.2017.06.030","article-title":"Comprehensive analysis of the tryptophan metabolome in urine of patients with acute intermittent porphyria","volume":"1060","author":"Gomez-Gomez","year":"2017","journal-title":"J Chromatography B"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052100234X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052100234X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T19:35:35Z","timestamp":1765222535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362052100234X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":10,"alternative-id":["S095362052100234X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2021.06.023","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperhomocysteinemia in patients with acute porphyrias: a possible effect of ALAS1 modulation by siRNAm therapy and its control by vitamin supplementation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2021.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}